Organization: Sanofi

Brain Canada & CQDM fund AbCellera’s cell screening platform technology

AbCellera Biologics Inc and the Univ of British Columbia (UBC) received non-dilutive funding of $1 million from pharma-based consortium CQDM and charitable organization Brain Canada Foundation to advance a discovery platform for next-generation antibody therapeutics. With the additional contribution of $450,000 from AbCellera, the program will leverage AbCellera’s high throughput, single-cell screening platform to allow rapid…

QLT exploring asset sale to boost shareholder value

QLT Inc — once one of Canada’s most highly valued technology companies — has established a special committee to explore options for selling some or all of its assets. The move follows declining sales of its lead products for age-related macular degeneration and prostate cancer combined with delays in bringing other products to market. The…